Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duplication of The <i>SOX3</i> Gene in an Sry-negative 46,XX Male with Associated Congenital Anomalies of Kidneys and the Urinary Tract: Case Report and Review of the Literature.

Balkan journal of medical genetics : BJMG·2019
Same author

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2017
Same author

Genetic, Genomic and Epigenomic Studies of Balkan Endemic Nephropathy (Ben).

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2016
Same author

New form of the journal Prilozi (Contributions) of the Macedonian Academy of Sciences and Arts, Section of Medical Sciences.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2016
Same author

Adverse events in apheresis: An update of the WAA registry data.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2016
Same author

Proteomics in diagnosis of prostate cancer.

Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)·2015

Related Experiment Video

Updated: Jul 10, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Hepatitis C in dialysis patients.

M Polenakovic1, P Dzekova, A Sikole

  • 1Macedonian Academy of Sciences and Arts, Skopje, R. Macedonia. maknefpo@mt.net.mk

Prilozi
|October 13, 2007
PubMed
Summary

Hepatitis C virus (HCV) is common in dialysis patients, increasing liver and cardiovascular disease risks. Treatment with interferon alpha is recommended before kidney transplantation to improve outcomes.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is prevalent in dialysis patients, posing significant health risks.
  • Risk factors for HCV spread include blood transfusions, dialysis duration, and unit prevalence.
  • Challenges in policy formulation stem from high prevalence, diagnostic limitations, and transmission uncertainties.

Purpose of the Study:

  • To review the epidemiology, natural history, and management of HCV infection in dialysis patients.
  • To highlight the impact of HCV on mortality and transplantation outcomes.
  • To discuss current treatment strategies and their implications.

Main Methods:

  • Literature review of studies on HCV in dialysis patients.
  • Analysis of risk factors, clinical course, and mortality.

Related Experiment Videos

Last Updated: Jul 10, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

  • Evaluation of treatment options, including interferon therapy.

    • Main Results:

    • HCV infection is common and associated with increased mortality, primarily from liver and cardiovascular diseases.
    • The clinical course is often asymptomatic with slow progression.
    • Pre-transplantation treatment is crucial as HCV negatively impacts graft and patient survival.

    Conclusions:

    • HCV poses a significant threat to dialysis patients, affecting both survival and transplant outcomes.
    • Interferon alpha is the current standard treatment, requiring careful monitoring.
    • Effective management and pre-transplant treatment are essential for improving patient prognosis.